Literature DB >> 18700783

1H NMR and UPLC-MS(E) statistical heterospectroscopy: characterization of drug metabolites (xenometabolome) in epidemiological studies.

Derek J Crockford1, Anthony D Maher, Kourosh R Ahmadi, Amy Barrett, Robert S Plumb, Ian D Wilson, Jeremy K Nicholson.   

Abstract

Statistical HeterospectroscopY (SHY) is a statistical strategy for the coanalysis of multiple spectroscopic data sets acquired in parallel on the same samples. This method operates through the analysis of the intrinsic covariance between signal intensities in the same and related molecular fingerprints measured by multiple spectroscopic techniques across cohorts of samples. Here, the method is applied to 600-MHz (1)H NMR and UPLC-TOF-MS (E) data obtained from human urine samples ( n = 86) from a subset of an epidemiological population unselected for any relevant phenotype or disease factor. We show that direct cross-correlation of spectral parameters, viz. chemical shifts from NMR and m/ z data from MS, together with fragment analysis from MS (E) scans, leads not only to the detection of numerous endogenous urinary metabolites but also the identification of drug metabolites that are part of the latent use of drugs by the population. We show previously unreported positive mode ions of ibuprofen metabolites with their NMR correlates and suggest the detection of new metabolites of disopyramide in the population samples. This approach is of great potential value in the description of population xenometabolomes and in population pharmacology studies, and indeed for drug metabolism studies in general.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18700783     DOI: 10.1021/ac801075m

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  13 in total

1.  Global metabolic profiling procedures for urine using UPLC-MS.

Authors:  Elizabeth J Want; Ian D Wilson; Helen Gika; Georgios Theodoridis; Robert S Plumb; John Shockcor; Elaine Holmes; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-06       Impact factor: 13.491

2.  Evaluation of GC-APCI/MS and GC-FID as a complementary platform.

Authors:  Tiziana Pacchiarotta; Ekaterina Nevedomskaya; Alegria Carrasco-Pancorbo; André M Deelder; Oleg A Mayboroda
Journal:  J Biomol Tech       Date:  2010-12

3.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

4.  Design and application of a data-independent precursor and product ion repository.

Authors:  Konstantinos Thalassinos; Johannes P C Vissers; Stefan Tenzer; Yishai Levin; J Will Thompson; David Daniel; Darrin Mann; Mark R DeLong; M Arthur Moseley; Antoine H America; Andrew K Ottens; Greg S Cavey; Georgios Efstathiou; James H Scrivens; James I Langridge; Scott J Geromanos
Journal:  J Am Soc Mass Spectrom       Date:  2012-07-31       Impact factor: 3.109

Review 5.  Can NMR solve some significant challenges in metabolomics?

Authors:  G A Nagana Gowda; Daniel Raftery
Journal:  J Magn Reson       Date:  2015-08-18       Impact factor: 2.229

Review 6.  Emerging new strategies for successful metabolite identification in metabolomics.

Authors:  Kerem Bingol; Lei Bruschweiler-Li; Dawei Li; Bo Zhang; Mouzhe Xie; Rafael Brüschweiler
Journal:  Bioanalysis       Date:  2016-02-26       Impact factor: 2.681

Review 7.  Metabolic phenotyping for discovery of urinary biomarkers of diet, xenobiotics and blood pressure in the INTERMAP Study: an overview.

Authors:  Queenie Chan; Ruey Leng Loo; Timothy M D Ebbels; Linda Van Horn; Martha L Daviglus; Jeremiah Stamler; Jeremy K Nicholson; Elaine Holmes; Paul Elliott
Journal:  Hypertens Res       Date:  2016-12-22       Impact factor: 3.872

Review 8.  Advances in NMR-based biofluid analysis and metabolite profiling.

Authors:  Shucha Zhang; G A Nagana Gowda; Tao Ye; Daniel Raftery
Journal:  Analyst       Date:  2010-04-09       Impact factor: 4.616

9.  Metabolic profiling and population screening of analgesic usage in nuclear magnetic resonance spectroscopy-based large-scale epidemiologic studies.

Authors:  Ruey Leng Loo; Muireann Coen; Timothy Ebbels; Olivier Cloarec; Elaine Maibaum; Magda Bictash; Ivan Yap; Paul Elliott; Jeremiah Stamler; Jeremy K Nicholson; Elaine Holmes
Journal:  Anal Chem       Date:  2009-07-01       Impact factor: 6.986

10.  Stable isotope- and mass spectrometry-based metabolomics as tools in drug metabolism: a study expanding tempol pharmacology.

Authors:  Fei Li; Xiaoyan Pang; Kristopher W Krausz; Changtao Jiang; Chi Chen; John A Cook; Murali C Krishna; James B Mitchell; Frank J Gonzalez; Andrew D Patterson
Journal:  J Proteome Res       Date:  2013-01-31       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.